In animal models of the synucleinopathies PD and MSA administration of FTY720, an S1P agonist, has been shown to ameliorate neurodegeneration and behavioral dysfunction associated with mitochondrial dysfunction via S1P receptors [45, 46]. Here, MBTPS1 is linked to Parkinson disease.